Key statistics
As of last trade Q32 Bio Inc (0T6G:LSE) traded at 45.60, -14.60% below its 52-week high of 53.40, set on Sep 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 45.60 |
Low | 45.60 |
Bid | -- |
Offer | -- |
Previous close | 45.60 |
Average volume | 60.88 |
---|---|
Shares outstanding | 12.06m |
Free float | 11.11m |
P/E (TTM) | -- |
Market cap | 546.19m USD |
EPS (TTM) | -16.24 USD |
Data delayed at least 20 minutes, as of Nov 08 2024 18:47 GMT.
More ▼
Press releases
- Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference
- Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
- Q32 Bio to Participate in Upcoming September Investor Conferences